VisCardia, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.viscardia.com
Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
Not Applicable
Not yet recruiting
- Conditions
- Heart Failure With Reduced Ejection Fraction
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- VisCardia Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT06552637
RECOVER-HF Pilot Study of SDS in Heart Failure
Not Applicable
Active, not recruiting
- Conditions
- Heart Failure With Reduced Ejection Fraction
- First Posted Date
- 2022-10-24
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- VisCardia Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT05592392
- Locations
- 🇬🇪
Tbilisi Heart And Vascular Clinic, Tbilisi, Georgia
🇺🇿Republican Specialized Scientific and Practical Medical Center for Surgery n.a. V. Vakhidov, Tashkent, Uzbekistan
VisONE Heart Failure Study: Pilot
Not Applicable
Completed
- Conditions
- Heart Failure With Reduced Ejection Fraction, HFrEF
- First Posted Date
- 2018-04-02
- Last Posted Date
- 2020-05-20
- Lead Sponsor
- VisCardia Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03484780
- Locations
- 🇬🇪
Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia
🇺🇦Kyiv City Heart Center, Kiev, Ukraine
🇺🇦Amosov National Institute of Cardiovascular Surgery, Kyiv, Ukraine
News
No news found